Switch to:
NovaBay Pharmaceuticals Inc (AMEX:NBY)
EV/EBITDA
-1.94 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, NovaBay Pharmaceuticals Inc's enterprise value is $33.51 Mil. NovaBay Pharmaceuticals Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2015 was $-17.26 Mil. Therefore, NovaBay Pharmaceuticals Inc's EV/EBITDA ratio for today is -1.94.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, NovaBay Pharmaceuticals Inc's stock price is $0.64. NovaBay Pharmaceuticals Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2015 was $-0.32. Therefore, NovaBay Pharmaceuticals Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

NovaBay Pharmaceuticals Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=33.508/-17.258
=-1.94

NovaBay Pharmaceuticals Inc's current Enterprise Value is $33.51 Mil.
NovaBay Pharmaceuticals Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2015 was -3.715 (Jun. 2014 ) + -4.069 (Sep. 2014 ) + -4.854 (Dec. 2014 ) + -4.62 (Mar. 2015 ) = $-17.26 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

NovaBay Pharmaceuticals Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=0.64/-0.317
=

NovaBay Pharmaceuticals Inc's share price for today is $0.64.
NovaBay Pharmaceuticals Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2015 was -0.06 (Jun. 2014 ) + -0.08 (Sep. 2014 ) + -0.087 (Dec. 2014 ) + -0.09 (Mar. 2015 ) = $-0.32.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

NovaBay Pharmaceuticals Inc Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebitda 0.000.00-10.25-1.2411.87-6.39-6.20-3.12-2.76-1.63

NovaBay Pharmaceuticals Inc Quarterly Data

Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15
ev2ebitda -3.12-4.30-3.91-4.24-2.76-2.80-1.85-2.02-1.63-2.12
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK